Your browser doesn't support javascript.
loading
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
AbdulJabbar, Khalid; Raza, Shan E Ahmed; Rosenthal, Rachel; Jamal-Hanjani, Mariam; Veeriah, Selvaraju; Akarca, Ayse; Lund, Tom; Moore, David A; Salgado, Roberto; Al Bakir, Maise; Zapata, Luis; Hiley, Crispin T; Officer, Leah; Sereno, Marco; Smith, Claire Rachel; Loi, Sherene; Hackshaw, Allan; Marafioti, Teresa; Quezada, Sergio A; McGranahan, Nicholas; Le Quesne, John; Swanton, Charles; Yuan, Yinyin.
Afiliação
  • AbdulJabbar K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Raza SEA; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Rosenthal R; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Jamal-Hanjani M; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Akarca A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Lund T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Moore DA; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Salgado R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Zapata L; Department of Cellular Pathology, University College London, University College Hospital, London, UK.
  • Hiley CT; Translational Immune Oncology Group, Centre for Molecular Medicine, Royal Marsden Hospital NHS Trust, London, UK.
  • Officer L; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Sereno M; Department of Cellular Pathology, University College London, University College Hospital, London, UK.
  • Smith CR; Department of Pathology, GZA-ZNA-Ziekenhuizen, Antwerp, Belgium.
  • Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Hackshaw A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Marafioti T; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Quezada SA; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Le Quesne J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Swanton C; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
  • Yuan Y; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Nat Med ; 26(7): 1054-1062, 2020 07.
Article em En | MEDLINE | ID: mdl-32461698
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Antígenos de Neoplasias / Recidiva Local de Neoplasia Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Antígenos de Neoplasias / Recidiva Local de Neoplasia Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article